Bone Biologics is a publicly traded company based in Burlington, MA and is focused on developing and marketing orthobiologic products. Our proprietary platform technology is NELL-1, a recombinant human protein growth factor that is essential for normal bone development.
- Currently finalizing pivotal animal studies
- Clearance to move into human studies in Australia
- Potential commercialization into $3 billion dollar orthobiologics market pending successful completion of pivotal human studies in U.S